Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,454 signal articles · 231 in last 24h · 132,887 total before filter · latest 56m ago
231last 24h
1166last 7d
203● bullish (7d)
123● bearish (7d)
208publishers
AllMacro281Earnings427M&A72Regulatory22Product10Analyst20
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga7d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization

What Could JPMorgan Chase (JPM) Lawsuits Mean For Future M And A Deals?
Simply Wall St.9d agobearish
What Could JPMorgan Chase (JPM) Lawsuits Mean For Future M And A Deals?

JPMorgan Chase (NYSE:JPM) and Morgan Stanley are facing ongoing shareholder lawsuits tied to recent multibillion dollar buyout deals that took public companies private. The complaints allege the banks facilitated undervalued sales to private equity buyers and breached fiduciary duties in their advisory roles. These cases are testing the scope of legal protections for large banks involved in M&A transactions under evolving corporate law. Investors are watching the proceedings for potential...

What Is Intuit (INTU) Facing In This New Investor Lawsuit?
Simply Wall St.9d agobearish
What Is Intuit (INTU) Facing In This New Investor Lawsuit?

Intuit (NasdaqGS: INTU) and several top executives face a new class action lawsuit alleging they misled investors about generative AI competition and Mailchimp performance. The complaint claims Intuit understated the competitive threat from generative AI tools and misrepresented trends in Mailchimp's business. Plaintiffs have expanded the suit to cover a longer class period, building on earlier litigation focused on similar issues. The case raises fresh questions about Intuit's disclosures...

Tesla (TSLA) Is Recalling Nearly 3 Million Vehicles In China
Simply Wall St.11d agobearish
Tesla (TSLA) Is Recalling Nearly 3 Million Vehicles In China

Tesla (NasdaqGS:TSLA) is recalling nearly 3 million vehicles in China due to potential safety issues with emergency door releases. The recall is the company’s largest in China to date and affects vehicles already on Chinese roads. Separately, Tesla has introduced a new Powerwall home battery leasing plan as competition in residential energy storage increases. The recall and the Powerwall shift could influence how regulators, consumers and investors view Tesla’s broader business model. This...

Is AST SpaceMobile (ASTS) At Risk From A $15 Million Fee Lawsuit?
Simply Wall St.13d agobearish
Is AST SpaceMobile (ASTS) At Risk From A $15 Million Fee Lawsuit?

AST SpaceMobile (NasdaqGS:ASTS) has been sued by Delclaux Partners over more than US$15 million in disputed contractual finder’s fees. The lawsuit centers on alleged unpaid compensation linked to financing arrangements that Delclaux Partners claims it helped source. The case raises questions about AST SpaceMobile’s contractual obligations and potential financial and reputational risks. This kind of legal and financing friction is not unique to AST SpaceMobile. It can be useful to compare...

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy
Simply Wall St.13d agoneutral
Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron’s portfolio, reinforcing the company’s focus on specialized, high-complexity immunology therapies. We’ll now examine how Pasatru’s FOP approval, as an ultra-rare...

The Bull Case For Alibaba (BABA) Could Change Following New Lawsuits Targeting Its AI And Disclosures
Simply Wall St.14d agobearish
The Bull Case For Alibaba (BABA) Could Change Following New Lawsuits Targeting Its AI And Disclosures

Alibaba Group Holding has faced a wave of securities fraud class action lawsuits after the U.S. Department of Defense labeled it a “Chinese military company” and reports emerged of alleged unauthorized use of third-party AI models, raising questions about its regulatory disclosures and AI practices. Beyond the legal risk, these cases highlight how deeply Alibaba’s emerging AI business is now intertwined with geopolitical scrutiny and compliance expectations in key markets. We’ll now examine...

Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?
Simply Wall St.15d agobearish
Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?

Hims & Hers Health (NYSE:HIMS) is facing a new consumer class action lawsuit alleging misrepresentation of user privacy and unauthorized sharing of sensitive health data. The lawsuit follows a recent FTC civil enforcement action against the company that raised similar concerns about handling of consumer health information. Plaintiffs claim the company misled users about how their health data would be used and shared, potentially affecting customer trust and future regulatory scrutiny. As...

UnitedHealth Group (UNH) Hit With Investor Lawsuit Over Governance And Cybersecurity Claims
Simply Wall St.15d agobearish
UnitedHealth Group (UNH) Hit With Investor Lawsuit Over Governance And Cybersecurity Claims

UnitedHealth Group (NYSE:UNH) is facing a major investor lawsuit alleging longstanding corporate governance and cybersecurity failures tied to its Change Healthcare acquisition. The complaint claims oversight gaps at UnitedHealth contributed to what plaintiffs describe as the largest healthcare data breach in U.S. history. Investors argue that weaknesses in internal controls and board level risk management left sensitive patient and claims data exposed. The case raises fresh questions for...